Detalles de la búsqueda
1.
The Relationships between Cerebrospinal Fluid Glial (CXCL12, CX3CL, YKL-40) and Synaptic Biomarkers (Ng, NPTXR) in Early Alzheimer's Disease.
Int J Mol Sci
; 24(17)2023 Aug 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37685973
2.
Evaluation of Synaptic and Axonal Dysfunction Biomarkers in Alzheimer's Disease and Mild Cognitive Impairment Based on CSF and Bioinformatic Analysis.
Int J Mol Sci
; 23(18)2022 Sep 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36142780
3.
Potential Utility of Cerebrospinal Fluid Glycoprotein Nonmetastatic Melanoma Protein B as a Neuroinflammatory Diagnostic Biomarker in Mild Cognitive Impairment and Alzheimer's Disease.
J Clin Med
; 12(14)2023 Jul 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37510803
4.
Comparative Analysis of Neurodegeneration and Axonal Dysfunction Biomarkers in the Cerebrospinal Fluid of Patients with Multiple Sclerosis.
J Clin Med
; 11(14)2022 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35887886
5.
Neurogranin and Neuronal Pentraxin Receptor as Synaptic Dysfunction Biomarkers in Alzheimer's Disease.
J Clin Med
; 10(19)2021 Oct 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34640593
6.
Fatty Acid Binding Protein 3 (FABP3) and Apolipoprotein E4 (ApoE4) as Lipid Metabolism-Related Biomarkers of Alzheimer's Disease.
J Clin Med
; 10(14)2021 Jul 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34300173
7.
The Clinical Significance of Cerebrospinal Fluid Reticulon 4 (RTN4) Levels in the Differential Diagnosis of Neurodegenerative Diseases.
J Clin Med
; 10(22)2021 Nov 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34830564
8.
Cerebrospinal Fluid and Blood CX3CL1 as a Potential Biomarker in Early Diagnosis and Prognosis of Dementia.
Curr Alzheimer Res
; 17(8): 709-721, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33167838
9.
The Relationship between Markers of Inflammation and Degeneration in the Central Nervous System and the Blood-Brain Barrier Impairment in Alzheimer's Disease.
J Alzheimers Dis
; 59(3): 903-912, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28697565
10.
Evaluation of visinin-like protein 1 concentrations in the cerebrospinal fluid of patients with mild cognitive impairment as a dynamic biomarker of Alzheimer's disease.
J Alzheimers Dis
; 43(3): 1031-7, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25159667
Resultados
1 -
10
de 10
1
Próxima >
>>